title: Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.
authors.affiliation: Dermatology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Masson Regnault
authors.affiliation: Dermatology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
authors.forename: J
authors.initials: J
authors.lastname: Ofaiche
authors.affiliation: Dermatology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
authors.forename: S
authors.initials: S
authors.lastname: Boulinguez
authors.affiliation: Dermatology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
authors.forename: E
authors.initials: E
authors.lastname: Tournier
authors.affiliation: Pathology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
authors.forename: P
authors.initials: P
authors.lastname: Rochaix
authors.affiliation: Dermatology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Paul
authors.affiliation: Pathology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.|INSERM UMR 1037-CRCT, Toulouse, France.
authors.forename: L
authors.initials: L
authors.lastname: Lamant
authors.affiliation: Dermatology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.|INSERM UMR 1037-CRCT, Toulouse, France.
authors.forename: N
authors.initials: N
authors.lastname: Meyer
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000209:etiology*; D008875:Middle Aged; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab